| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/25/2006 | US7033770 Comprises winglesslint 8D (Wnt-8D) polypeptides for treating asthma, nervous system, psychological, alzheimer, cancer, cardiomyopathies, lung and kidney disorders; wound healing agents; tissue engineering |
| 04/25/2006 | US7033769 identifying microbial peptides such as cercopins then screening combinatorial libraries; biochemical immobilization; solid phase synthesis |
| 04/25/2006 | US7033768 Reverse two-hybrid systems |
| 04/25/2006 | US7033767 Genes regulating programmed cell death |
| 04/25/2006 | US7033766 Detecting binding of target particles to Lantibiotic polypeptide; obtain lantibiotic cells, incubate with target particles, monitor adjustment in activity of particles |
| 04/25/2006 | US7033765 targeting sodium ion channel proteins; tissue-targeted therapy |
| 04/25/2006 | US7033764 Method for sequencing nucleic acid molecules |
| 04/25/2006 | US7033762 Single nucleotide amplification and detection by polymerase |
| 04/25/2006 | US7033761 aspirating solution into dispensers comprising pipette tips connected to syringe pump, pressurizing, then applying electromechanical force to spot droplets; for tissue-targeted diagnosis/therapy |
| 04/25/2006 | US7033760 Metallic solid supports modified with nucleic acids |
| 04/25/2006 | US7033757 Detecting mutation in sample; obtain nucleotide sequences, incubate with primer, hybridize, cleave nucleotide sequences, remove segments, detect mutation |
| 04/25/2006 | US7033755 Diagnostics and therapeutics for glaucoma |
| 04/25/2006 | US7033754 comprises identifier binding ligands; solid phase synthesis |
| 04/25/2006 | US7033751 Comprises viral glycoprotein fusion with glutathione s-tranferase (GST) or thioredoxin for use as diagnostic tool in screening blood products for retroviral infection |
| 04/25/2006 | US7033748 Detection of prefrential microorganisms in sample, obtain cells, culture, propagate detect expression of bacterial prteins, the presence of bacterial protein indnicates infection |
| 04/25/2006 | US7033747 Apparatus for use in the detection of preferential targets in sample |
| 04/25/2006 | US7033592 Useful in vaccines, and monoclonal antibodies against said immunogenic surface proteins; hybridoma cell line that produes said antibodies; use in diagnostic kits for determining presence, onset, or decrease in Leptospiral infection |
| 04/25/2006 | US7033473 For analysis of antibodies |
| 04/25/2006 | US7032662 injecting tracer in oil well; analyzing recovered fluid to determine concentration of tracer ; quantitative analysis |
| 04/25/2006 | US7032445 System and method for automatically measuring and tracking a feature of material used during a manufacturing process |
| 04/25/2006 | US7032444 Module for extracting gas from an underground liquid and installation equipped therewith |
| 04/25/2006 | US7032431 Non-invasive, miniature, breath monitoring apparatus |
| 04/25/2006 | CA2521142A1 Ligand-receptor tracking assays |
| 04/25/2006 | CA2408348C Mixed cell systems for the detection of viruses |
| 04/25/2006 | CA2380477C Gas sensor with phased heaters for increased sensitivity |
| 04/25/2006 | CA2353520C Animal model for psoriasis for the prevention and treatment of psoriasis in humans |
| 04/25/2006 | CA2351796C Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
| 04/25/2006 | CA2322037C Meat color imaging system for palatability and yield prediction |
| 04/25/2006 | CA2215528C Method for diagnosing a patient for chlamydia |
| 04/22/2006 | CA2481452A1 Novel purified polypeptides from streptococcus pneumoniae |
| 04/21/2006 | CA2485668A1 Method and system for detecting characteristics of lumber using end scanning |
| 04/20/2006 | WO2006042304A1 Concentration determination in a diffusion barrier layer |
| 04/20/2006 | WO2006042237A2 B7-h1 and methods of diagnosis, prognosis, and treatment of cancer |
| 04/20/2006 | WO2006042192A2 Relevance of achieved levels of markers of systemic inflammation following treatment |
| 04/20/2006 | WO2006042111A2 Raman-active particles and methods of making and using them |
| 04/20/2006 | WO2006042109A2 An apparatus for and method of sampling and collecting powders flowing in a gas stream |
| 04/20/2006 | WO2006042089A2 Methods and kits for detecting heparin/platelet factor 4 antibodies |
| 04/20/2006 | WO2006042035A2 Method of monitoring anti-tumor activity of an hdac inhibitor |
| 04/20/2006 | WO2006042013A2 Systems, method and devices for monitoring fluids |
| 04/20/2006 | WO2006041959A2 Detection of elevated levels of her-2/neu protein on circulating cancer cells and treatment |
| 04/20/2006 | WO2006041927A2 Food quality sensor and methods thereof |
| 04/20/2006 | WO2006041896A2 Detecting cell membrane protein endocytosis |
| 04/20/2006 | WO2006041745A2 Two-color chemiluminescent microarray system |
| 04/20/2006 | WO2006041617A1 Biodegradable cationic polymers |
| 04/20/2006 | WO2006041537A1 Lateral flow device for the detection of large pathogens |
| 04/20/2006 | WO2006041488A1 Immortalized hepatocytes |
| 04/20/2006 | WO2006041392A1 Preparation and use of a reactive solid support surface |
| 04/20/2006 | WO2006041214A1 Prevention or improvement of wrinkles by using adam activation inhibitor |
| 04/20/2006 | WO2006041211A1 Protein capable of binding to plasticizer |
| 04/20/2006 | WO2006041205A1 Angiogenesis promoter |
| 04/20/2006 | WO2006041194A1 LINKER FOR CONSTRUCTING mRNA-PUROMYCIN-PROTEIN CONJUGATE |
| 04/20/2006 | WO2006040958A1 Epitope peptide to polymyalgia rheumatica disease antibody and testing reagent for polymyalgia rheumatica disease |
| 04/20/2006 | WO2006040594A2 Nek kinase (nima related kinase) proteins |
| 04/20/2006 | WO2006040551A2 Compartmentalised screening by microfluidic control |
| 04/20/2006 | WO2006040494A1 Method for the in vitro exclusion diagnosis of acute coronary syndromes |
| 04/20/2006 | WO2006040481A2 Method for diagnosing and treating crohn's disease |
| 04/20/2006 | WO2006040409A1 Method and kit for detecting a risk of acute myocardial infarction |
| 04/20/2006 | WO2006040357A2 Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases |
| 04/20/2006 | WO2006040163A1 Monoclonal antibody against frizzled receptors |
| 04/20/2006 | WO2006040142A2 Method for detecting and/or determining the concentration of at least one ligand |
| 04/20/2006 | WO2006040106A1 A single use, self-contained assay device for quantitative and qualitative measurements |
| 04/20/2006 | WO2006040083A1 Analytical test element with wireless data transmission |
| 04/20/2006 | WO2006040047A2 Diagnostics and therapeutics for diseases associated with rho/rac-interacting citron kinase (cit) |
| 04/20/2006 | WO2006033130A3 Rapid monitoring system for blood groups and immunohematological reaction detection |
| 04/20/2006 | WO2006021888A3 Dihydrofolate reductase inhibition by epigallocatechin gallate compounds |
| 04/20/2006 | WO2006016392A3 Complex able to detect an analyte, method for its preparation and uses thereof |
| 04/20/2006 | WO2006002841A3 Analysis method |
| 04/20/2006 | WO2006002100A3 Diagnostic and screening methods and kits associated with proteolytic activity |
| 04/20/2006 | WO2005124345A3 Method of determining the presence and/or concentration of substances of interest in fluids |
| 04/20/2006 | WO2005124344A8 Method for detecting anti-transglutaminase antibodies in a saliva sample |
| 04/20/2006 | WO2005120195A3 Reservoir simulation |
| 04/20/2006 | WO2005115363A9 Method for treating skeletal disorders resulting from fgfr malfunction |
| 04/20/2006 | WO2005113524A8 Fluorescent method and compounds to monitor protein-lipid binding |
| 04/20/2006 | WO2005112969A3 Herstatin or intron 8-encoded domain thereof for modulating signaling mediated by igf-1 receptor and erbb receptors |
| 04/20/2006 | WO2005098440A3 Methods for identifying agents useful for the treatment of neurodegenerative diseases |
| 04/20/2006 | WO2005094467A3 Methods for reducing the range in concentrations of analyte species in a sample |
| 04/20/2006 | WO2005093431A3 Methods for detecting calcium ion influx |
| 04/20/2006 | WO2005089315A3 Methods and compositions related to skcg-1, a tumor suppressor gene |
| 04/20/2006 | WO2005085867A3 Screening method for emulators of neural activity and digestive system using gpr35 |
| 04/20/2006 | WO2005084223A8 Methods and compositions for hair growth |
| 04/20/2006 | WO2005084109A3 Cancer specific gene mh15 |
| 04/20/2006 | WO2005078117A3 Diagnostics and therapeutics for diseases associated with kallikrein 6 (klk6) |
| 04/20/2006 | WO2005072341A3 Detection of mesothelin-/megakaryocyte potentiating factor-related peptides in peritoneal fluid for assessment of the peritoneum and the peritoneal cavity |
| 04/20/2006 | WO2005052125A3 24p3 receptors and uses thereof |
| 04/20/2006 | WO2005049832A3 FcϜRIIA-SPECIFIC NUCLEIC ACID INTERFERENCE |
| 04/20/2006 | WO2005040751A3 Decontamination and concentration kit for mycobacteria |
| 04/20/2006 | WO2005034840A8 Identification of kinase inhibitors |
| 04/20/2006 | WO2005019423A3 Methods and compositions comprising fatp5 for use in the diagnosis and treatment of metabolic disorders |
| 04/20/2006 | WO2005017189A3 Neural cell assay |
| 04/20/2006 | WO2004051222A3 Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases |
| 04/20/2006 | WO2004044011A3 Combinatorial libraries of monomer domains |
| 04/20/2006 | WO2003047514A3 Reducing myelin-mediated inhibition of axon regeneration |
| 04/20/2006 | US20060085139 System, method, and computer program product for extraction, gathering, manipulation, and analysis of peak data from an automated sequencer |
| 04/20/2006 | US20060085137 Micropressors, devices and methods for use in analyte monitoring systems |
| 04/20/2006 | US20060085020 Tissue penetration device |
| 04/20/2006 | US20060084797 High affinity TGFbeta nucleic acid ligands and inhibitors |
| 04/20/2006 | US20060084790 P-Rex1, a ptdins (3,4,5) p3-g-beta-gamma-regulated guanine-nucleotide exchange factor for rac |
| 04/20/2006 | US20060084696 FIBROSIS; ALZHEIMER'S DISEASE, Parkinson's disease, autoimmune disease, wound healing, osteoporosis; ANTIARTHRITIC AGENTS, anticholesterol agents |
| 04/20/2006 | US20060084618 Adiponectin promoter and use thereof |
| 04/20/2006 | US20060084600 Human homologues of fused gene |